Skip to main content

Want a detailed portfolio tracker?

Cognition Therapeutics (CGTX) P/E (2021 - 2026)

Cognition Therapeutics (CGTX) P/E from Dec 31, 2021 to Jul 21, 2026. The TTM Cognition Therapeutics (CGTX) P/E is -2.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cognition Therapeutics (CGTX)

YearP/EChange
2026-2.11-12.56%
2025-2.41+167.51%
2024-0.90-62.65%
2023-2.41+18.33%
2022-2.04-89.36%
2021-19.14N/A

Comparison Cognition Therapeutics (CGTX) P/E with competitors

Cognition Therapeutics (CGTX) P/E is -2.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.20%
ENLVEnlivex Ltd0.07-103.55%
FGENFibroGen Inc0.24-111.40%
CHRSCoherus Biosciences Inc0.85-140.29%
FBIOFortress Biotech Inc0.95-145.06%
ORMPOramed Pharmaceuticals Inc1.50-171.36%
AGENAgenus Inc3.01-242.89%
INVAInnoviva Inc3.15-249.75%
VXRTVaxart Inc3.55-268.54%
CRMDCorMedix Inc3.63-272.28%
CVACCureVac N.V.4.45-311.08%
GLPGGalapagos NV4.86-330.70%
SRPTSarepta Therapeutics Inc4.88-331.80%
ABEOAbeona Therapeutics Inc5.39-355.80%
ABUSArbutus Biopharma Corp5.60-365.68%
ZVRAZevra Therapeutics Inc5.89-379.52%
SPROSpero Therapeutics Inc6.23-395.72%
RIGLRigel Pharmaceuticals6.87-426.28%
SLXNSilexion Therapeutics Corp7.30-446.41%
OMEROmeros Corporation9.26-539.60%
AUPHAurinia Pharmaceuticals Inc9.58-555.09%
PLXProtalix BioTherapeutics Inc10.89-617.10%
ACADAcadia Pharmaceuticals Inc11.73-656.86%
TBPHTheravance Biopharma Inc12.26-682.20%
ADMAAdma Biologics Inc12.42-689.61%
HRMYHarmony Biosciences Holdings Inc13.82-756.18%
SABSSAB Biotherapeutics Inc14.14-771.18%
NAGENiagen Bioscience Inc14.82-803.56%
INCYIncyte Corp15.82-851.25%
REGNRegeneron Pharmaceuticals Inc15.86-852.87%
PBYIPuma Biotechnology Inc17.32-922.14%
CPRXCatalyst Pharmaceuticals Inc17.44-928.01%
EXELExelixis Inc17.54-932.70%
TGTXTG Therapeutics Inc18.97-1000.50%
MDXGMimedx Group Inc20.55-1075.82%
XOMAXOMA Royalty Corp22.87-1186.11%
ARGXArgen X SE24.30-1253.69%
CTMXCytomX Therapeutics Inc24.82-1278.53%
XOMAOXOMA Royalty Corp25.34-1303.39%
HALOHalozyme Therapeutics Inc25.62-1316.64%
XOMAPXOMA Royalty Corp25.67-1318.84%
VRTXVertex Pharmaceuticals Inc27.99-1429.21%
RPRXRoyalty Pharma plc - Class A28.69-1462.11%
SLNOSoleno Therapeutics Inc29.02-1477.67%
ASNDAscendis Pharma A/S30.09-1528.49%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1900.09%
APLSApellis Pharmaceuticals Inc39.02-1952.76%
BMRNBiomarin Pharmaceutical Inc42.21-2104.25%
KRYSKrystal Biotech Inc45.34-2252.95%
ONCBeiGene Ltd69.54-3401.84%
PHARPharming Group N.V.75.03-3662.28%
TECHBio-Techne Corp101.96-4941.07%
VCELVericel Corp109.92-5319.16%
ALNYAlnylam Pharmaceuticals Inc117.96-5701.08%
GMABGenmab140.29-6761.13%
TLXTelix Pharmaceuticals Ltd162.15-7799.16%
CORTCorcept Therapeutics Inc212.86-10206.66%